Stocks and Investing Stocks and Investing
Wed, May 11, 2022
Tue, May 10, 2022

Gena Wang Maintained (BLUE) at Sell with Decreased Target to $3 on, May 10th, 2022


Published on 2024-10-27 20:58:55 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "bluebird bio, Inc." (BLUE) at Sell with Decreased Target from $4 to $3 on, May 10th, 2022.

Gena has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 3 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 6th, 2022
  • Yaron Werber of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, April 6th, 2022
  • Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Tuesday, March 8th, 2022


This is the rating of the analyst that currently disagrees with Gena


  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $5 on, Monday, March 7th, 2022
Contributing Sources